Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. The company pioneered the direct-to-consumer model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a force of more than 1,000 highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources, scores, and routes high-quality sales leads. The company has three core business lines: SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home. SelectQuote Senior, the largest and fastest-growing business, serves the needs of a demographic that sees 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans from 15 leading, nationally-recognized carriers, as well as prescription drug plan, dental, vision and hearing plans.
IPO Year: 2020
Exchange: NYSE
Website: selectquote.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/30/2024 | $4.50 | Buy | Craig Hallum |
| 2/29/2024 | $5.00 | Outperform | Noble Capital Markets |
| 4/1/2022 | $4.00 | Neutral | Credit Suisse |
| 2/8/2022 | $9.00 → $5.00 | Equal Weight | Barclays |
| 2/8/2022 | $13.00 → $3.00 | Sector Perform | RBC Capital |
| 2/8/2022 | $20.00 → $4.00 | Overweight → Neutral | Piper Sandler |
| 2/8/2022 | $14.00 → $4.00 | Outperform → Neutral | Credit Suisse |
| 1/18/2022 | $21.00 → $9.00 | Overweight → Equal Weight | Barclays |
| 1/4/2022 | $11.00 | Outperform → In-Line | Evercore ISI Group |
| 11/19/2021 | $12.00 | Hold | Jefferies |
8-K - SelectQuote, Inc. (0001794783) (Filer)
10-Q - SelectQuote, Inc. (0001794783) (Filer)
8-K - SelectQuote, Inc. (0001794783) (Filer)
S-8 - SelectQuote, Inc. (0001794783) (Filer)
8-K/A - SelectQuote, Inc. (0001794783) (Filer)
8-K - SelectQuote, Inc. (0001794783) (Filer)
DEFA14A - SelectQuote, Inc. (0001794783) (Filer)
DEF 14A - SelectQuote, Inc. (0001794783) (Filer)
10-K - SelectQuote, Inc. (0001794783) (Filer)
8-K - SelectQuote, Inc. (0001794783) (Filer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur
Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50
Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00
Credit Suisse resumed coverage of SelectQuote with a rating of Neutral and set a new price target of $4.00
Barclays reiterated coverage of SelectQuote with a rating of Equal Weight and set a new price target of $5.00 from $9.00 previously
RBC Capital reiterated coverage of SelectQuote with a rating of Sector Perform and set a new price target of $3.00 from $13.00 previously
Piper Sandler downgraded SelectQuote from Overweight to Neutral and set a new price target of $4.00 from $20.00 previously
Credit Suisse downgraded SelectQuote from Outperform to Neutral and set a new price target of $4.00 from $14.00 previously
Barclays downgraded SelectQuote from Overweight to Equal Weight and set a new price target of $9.00 from $21.00 previously
Evercore ISI Group downgraded SelectQuote from Outperform to In-Line and set a new price target of $11.00
Jefferies initiated coverage of SelectQuote with a rating of Hold and set a new price target of $12.00
First Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $292.3 million Net loss of $44.5 million Adjusted EBITDA* of $(1.7) million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.425 billion to $1.525 billion Net income (loss) expected in a range of $(59) million to $3 million Adjusted EBITDA* expected in a range of $100 million to $130 million First Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $92.9 million Adjusted EBITDA* of $7.7 million Approved Medicare Advantage policies of 91,680 Healthcare Services Revenue of $155.7 million Adjusted EBITDA* of $4.9 million 86,521 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its first quarter 2025 financial results before market open on Monday, November 4, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (November 4, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I1559258472 After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Re
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly-growing Healthcare Services platform, today announced the completion of a $100 million securitization transaction on October 15, 2024. Securitization provides advanced financing against the Company's expected collections for policies previously sold. The Company's receivables totaled approximately $1 billion as of June 30, 2024, and only a portion of the total receivables balance was securitized in this transaction. The Company will use the proceeds from this first securitization to pay down a portion of its outstanding term debt. The new securitized debt offers a materially lower cos
Fourth Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $307.2 million Net loss of $31.0 million Adjusted EBITDA* of $14.4 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.4 billion to $1.5 billion Net loss expected in a range of $42 million to $6 million Adjusted EBITDA* expected in a range of $90 million to $120 million Fourth Quarter Fiscal Year 2024 – Segment Highlights Senior Revenue of $114.1 million Adjusted EBITDA* of $27.9 million Approved Medicare Advantage policies of 107,272 Healthcare Services Revenue of $145.2 million Adjusted EBITDA* of $0.9 million Approximately 82,000 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday, September 13, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (September 13, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=7297aa9f&confId=70516 After registering, a confirmation will be sent via email, including dial in details and unique conf
SelectQuote, Inc. (NYSE:SLQT) today announced that SelectRx, the company's full-service medication management pharmacy that serves all 50 states, will open a third fulfillment facility in Olathe, Kansas, to serve its rapidly expanding customer base, alongside its existing facilities in Monaca, Pennsylvania, and Indianapolis, Indiana. SelectQuote launched the SelectRx business in 2021 as part of its Healthcare Services Division after acquiring two smaller pharmacy operations. In just over three years, SelectRx has grown its membership from under 5,000 to over 75,000 members who receive regular prescription shipments in adherence-friendly packaging. The new 54,000 square foot state-of-the-a
Third Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $376.4 million Net income of $8.6 million Adjusted EBITDA* of $46.6 million Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million Third Quarter of Fiscal Year 2024 – Segment Highlights Senior Revenue of $204.3 million Adjusted EBITDA* of $61.5 million Approved Medicar
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced the date for the release of its third quarter financial results and upcoming RBC conference presentation. Fiscal Third Quarter 2024 Earnings Conference Call SelectQuote will release its fiscal third quarter 2024 financial results before market open on Thursday, May 9, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 9, 2024) at 9:00 am ET to discuss the results. To register for this conference call, please use this link: https://www.netro
Second Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $405.4 million Net income of $19.4 million Adjusted EBITDA* of $67.4 million Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.23 billion to $1.3 billion vs prior range of $1.05 billion to $1.2 billion Net loss expected in a range of $45 million to $22 million vs prior range of $50 million to $22 million Adjusted EBITDA* expected in a range of $90 million to $105 million vs prior range of $80 million to $105 million Second Quarter of Fiscal Year 2024 – Segment Highlights Senior Revenue of $247.5 million Adjusted EBITDA* of $78.7 million Approved Medic
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, announced today that it will release its fiscal second quarter 2024 financial results prior to market open on Wednesday, February 7, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (February 7, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=3bad4d79&confId=59966 After registering, a confirmation will be sent via email, including dial in details and unique con
Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million
SelectQuote (NYSE:SLQT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $376.400 million which beat the analyst consensus estimate of $339.700 million by 10.80 percent. This is a 25.72 percent increase over sales of $299.398 million the same period last year.
Shares of Perficient, Inc (NASDAQ:PRFT) shares rose sharply during Monday's session after the company disclosed an acquisition deal and first-quarter FY24 results. The company stated that it has entered into a definitive deal to be acquired by an affiliate of BPEA Private Equity Fund VIII (EQT Asia), part of EQT AB in an all-cash transaction at an enterprise value of around $3.0 billion. Perficient shares jumped 53% to $73.60 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 19% to $5.30 following strong first-quarter results. Pacific Biosciences of California, Inc. (NASDAQ:PACB) rose 15% to
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers SelectQuote (NYSE:SLQT) shares moved upwards by 6.25% to $1.87 during Friday's regular session. The current volume of 600.8K shares is 0% of SelectQuote's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $300.8 million. Fanhua (NASDAQ:FANH) shares rose 5.53% to $5.05. The current volume of 17.6K shares is 0% of Fanhua's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $272.3 million. Heritage Insurance Hldgs (NYSE:HRTG) stock inc
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers Huize Holding (NASDAQ:HUIZ) stock increased by 7.74% to $0.62 during Thursday's regular session. The current volume of 8.3K shares is 0% of Huize Holding's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $35.9 million. Kingstone Companies (NASDAQ:KINS) stock increased by 5.33% to $3.87. As of 12:40 EST, Kingstone Companies's stock is trading at a volume of 989, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $41.2 million. Cheche Group
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers Marpai (NASDAQ:MRAI) stock moved upwards by 29.41% to $1.98 during Wednesday's regular session. Trading volume for Marpai's stock is 5.7 million as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $15.4 million. Hippo Holdings (NYSE:HIPO) stock increased by 23.58% to $17.87. Trading volume for Hippo Holdings's stock is 817.1K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $429.9 million. The company's, Q4 earnings cam
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers Reliance Global Group (NASDAQ:RELI) stock moved upwards by 18.84% to $0.61 during Monday's regular session. The current volume of 2.2 million shares is 0% of Reliance Global Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $2.7 million. Crawford (NYSE:CRD) shares increased by 5.84% to $12.72. As of 12:40 EST, this security is trading at a volume of 45.1K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at 6219
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers Fidelis Insurance Hldgs (NYSE:FIHL) shares increased by 14.5% to $17.13 during Friday's regular session. As of 12:40 EST, this security is trading at a volume of 632.4K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.9 billion. As per the news, the Q4 earnings report came out yesterday. Marpai (NASDAQ:MRAI) stock moved upwards by 12.58% to $1.61. Marpai's stock is trading at a volume of 58.8K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market c
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. Gainers Root (NASDAQ:ROOT) shares rose 16.33% to $32.54 during Thursday's regular session. Root's stock is trading at a volume of 1.4 million shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $476.6 million. SelectQuote (NYSE:SLQT) shares rose 8.95% to $1.94. The current volume of 1.1 million shares is 0% of SelectQuote's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $307.5 million. Conifer Holdings (NASDAQ:CNFR) stock mo
First Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $292.3 million Net loss of $44.5 million Adjusted EBITDA* of $(1.7) million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.425 billion to $1.525 billion Net income (loss) expected in a range of $(59) million to $3 million Adjusted EBITDA* expected in a range of $100 million to $130 million First Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $92.9 million Adjusted EBITDA* of $7.7 million Approved Medicare Advantage policies of 91,680 Healthcare Services Revenue of $155.7 million Adjusted EBITDA* of $4.9 million 86,521 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its first quarter 2025 financial results before market open on Monday, November 4, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (November 4, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I1559258472 After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Re
Fourth Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $307.2 million Net loss of $31.0 million Adjusted EBITDA* of $14.4 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.4 billion to $1.5 billion Net loss expected in a range of $42 million to $6 million Adjusted EBITDA* expected in a range of $90 million to $120 million Fourth Quarter Fiscal Year 2024 – Segment Highlights Senior Revenue of $114.1 million Adjusted EBITDA* of $27.9 million Approved Medicare Advantage policies of 107,272 Healthcare Services Revenue of $145.2 million Adjusted EBITDA* of $0.9 million Approximately 82,000 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday, September 13, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (September 13, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=7297aa9f&confId=70516 After registering, a confirmation will be sent via email, including dial in details and unique conf
Third Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $376.4 million Net income of $8.6 million Adjusted EBITDA* of $46.6 million Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million Third Quarter of Fiscal Year 2024 – Segment Highlights Senior Revenue of $204.3 million Adjusted EBITDA* of $61.5 million Approved Medicar
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced the date for the release of its third quarter financial results and upcoming RBC conference presentation. Fiscal Third Quarter 2024 Earnings Conference Call SelectQuote will release its fiscal third quarter 2024 financial results before market open on Thursday, May 9, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 9, 2024) at 9:00 am ET to discuss the results. To register for this conference call, please use this link: https://www.netro
Second Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $405.4 million Net income of $19.4 million Adjusted EBITDA* of $67.4 million Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.23 billion to $1.3 billion vs prior range of $1.05 billion to $1.2 billion Net loss expected in a range of $45 million to $22 million vs prior range of $50 million to $22 million Adjusted EBITDA* expected in a range of $90 million to $105 million vs prior range of $80 million to $105 million Second Quarter of Fiscal Year 2024 – Segment Highlights Senior Revenue of $247.5 million Adjusted EBITDA* of $78.7 million Approved Medic
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, announced today that it will release its fiscal second quarter 2024 financial results prior to market open on Wednesday, February 7, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (February 7, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=3bad4d79&confId=59966 After registering, a confirmation will be sent via email, including dial in details and unique con
First Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $232.7 million Net loss of $31.1 million Adjusted EBITDA* of $(11.4) million Reaffirming Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.05 billion to $1.2 billion Net loss expected in a range of $50 million to $22 million Adjusted EBITDA* expected in a range of $80 million to $105 million First Quarter of Fiscal Year 2024 – Segment Highlights Senior Revenue of $89.9 million Adjusted EBITDA* of $(1.3) million Approved Medicare Advantage policies of 97,681 Healthcare Services Revenue of $97.4 million Adjusted EBITDA* of $2.3 million Over 52,000 Se
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced the date for the release of its first quarter financial results and upcoming Sidoti conference presentation. Fiscal First Quarter 2024 Earnings Conference Call SelectQuote will release its fiscal first quarter 2024 financial results after market close on Thursday, November 2, 2023. Tim Danker, Chief Executive Officer, and Ryan Clement, Chief Financial Officer, will host a conference call on the day of the release (November 2, 2023) at 4:30 pm ET to discuss the results. To register for this conference call, please use this link: http
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G - SelectQuote, Inc. (0001794783) (Subject)